Bon Natural Life Ltd. Files 2024 Annual Report
Ticker: BON · Form: 20-F · Filed: Jan 28, 2025 · CIK: 1816815
Sentiment: neutral
Topics: annual-report, 20-f, financials
TL;DR
Bon Natural Life filed its 2024 20-F, showing financials up to Sept 30, 2024.
AI Summary
Bon Natural Life Ltd. filed its 20-F annual report for the fiscal year ending September 30, 2024. The filing details the company's financial performance and business operations, including its principal executive offices located in Xian, Shaanxi, China. The report covers financial data from fiscal years 2021 through 2024.
Why It Matters
This filing provides investors and stakeholders with a comprehensive overview of Bon Natural Life Ltd.'s financial health and strategic direction for the past fiscal year, crucial for investment decisions.
Risk Assessment
Risk Level: medium — As a foreign private issuer filing a 20-F, the company operates under different regulatory frameworks and may present unique risks to investors compared to domestic companies.
Key Numbers
- 2024-09-30 — Fiscal Year End (The end date for the reporting period covered by the 20-F.)
- 2025-01-28 — Filing Date (The date the 20-F report was officially submitted to the SEC.)
Key Players & Entities
- Bon Natural Life Ltd (company) — Filer of the 20-F report
- Xian (location) — Location of principal executive offices
- Shaanxi (location) — State of principal executive offices
FAQ
What is the primary business of Bon Natural Life Ltd?
The filing indicates Bon Natural Life Ltd. operates in the MEDICINAL CHEMICALS & BOTANICAL PRODUCTS sector (SIC code 2833).
What period does this 20-F filing cover?
This 20-F filing covers the fiscal year ending September 30, 2024.
Where are Bon Natural Life Ltd.'s principal executive offices located?
The company's principal executive offices are located at Room 601, Block C, Gazelle Valley, No.69 Jinye Road, High-Tech Zone, Xian, Shaanxi, China.
What is the SEC file number for Bon Natural Life Ltd?
The SEC file number for Bon Natural Life Ltd. is 001-40517.
When was this 20-F form filed with the SEC?
This 20-F form was filed with the SEC on January 28, 2025.
Filing Stats: 4,632 words · 19 min read · ~15 pages · Grade level 12 · Accepted 2025-01-27 18:12:08
Key Financial Figures
- $0.001 — nge On Which Registered Common Stock, $0.001 par value BON NASDAQ Capital Market
- $9 million — e been as follows: 1) On June 29, 2021, $9 million was transferred from Bon Natural Life t
- $1 million — sidiary in the PRC. 2) On July 9, 2021, $1 million was transferred from Bon Natural Life t
- $630,000 — in August 2021. 3) On January 17, 2023, $630,000 was transferred from Bon Natural Life t
Filing Documents
- form20-f.htm (20-F) — 3127KB
- ex31-1.htm (EX-31.1) — 17KB
- ex31-2.htm (EX-31.2) — 17KB
- ex32-1.htm (EX-32.1) — 7KB
- ex32-2.htm (EX-32.2) — 7KB
- form20-f_001.jpg (GRAPHIC) — 181KB
- form20-f_002.jpg (GRAPHIC) — 181KB
- form20-f_003.jpg (GRAPHIC) — 229KB
- form20-f_004.jpg (GRAPHIC) — 64KB
- form20-f_005.jpg (GRAPHIC) — 161KB
- logo_001.jpg (GRAPHIC) — 4KB
- 0001493152-25-003851.txt ( ) — 14360KB
- bon-20240930.xsd (EX-101.SCH) — 82KB
- bon-20240930_cal.xml (EX-101.CAL) — 127KB
- bon-20240930_def.xml (EX-101.DEF) — 327KB
- bon-20240930_lab.xml (EX-101.LAB) — 608KB
- bon-20240930_pre.xml (EX-101.PRE) — 502KB
- form20-f_htm.xml (XML) — 1789KB
Selected Financial Data
Selected Financial Data 6 B. Capitalization and Indebtedness 7 C. Reasons for the Offer and Use of Proceeds 7 D.
Risk Factors
Risk Factors 7 ITEM 4. INFORMATION ON THE COMPANY 41 A. History and Development of the Company 41 B. Business Overview 48 C. Organizational Structure 78 D. Property, Plants and Equipment 82 ITEM 4A. UNRESOLVED STAFF COMMENTS 83 ITEM 5. OPERATING AND FINANCIAL REVIEW AND PROSPECTS 83 A. Operating Results 83 B. Liquidity and Capital Resources 97 C. Research and Development, Patents and Licenses, Etc. 99 D. Trend Information 99 E. Off Balance Sheet Arrangements 99 F. Tabular Disclosure of Contractual Obligations 99 G. Safe Harbor 102 ITEM 6. DIRECTORS, SENIOR MANAGEMENT AND EMPLOYEES 102 A. Directors and Senior Management 102 B. Compensation 106 C. Board Practices 107 D. Employees 110 E. Share Ownership 110 ITEM 7. MAJOR SHAREHOLDERS AND RELATED PARTY TRANSACTIONS 112 A. Major Shareholders 112 B. Related Party Transactions 112 C. Interests of Experts and Counsel 113 i ITEM 8. FINANCIAL INFORMATION 113 A. Consolidated Statements and Other Financial Information 113 B. Significant Changes 114 ITEM 9. THE OFFER AND LISTING 114 A. Offer and Listing Details 114 B. Plan of Distribution 114 C. Markets 114 D. Selling Shareholders 115 E.
Dilution
Dilution 115 F. Expenses of the Issue 115 ITEM 10. ADDITIONAL INFORMATION 115 A. Share Capital 115 B. Memorandum and Articles of Association 115 C. Material Contracts 118 D. Exchange Controls 119 E. Taxation 121 F. Dividends and Paying Agents 129 G. 129 H. Documents on Display 130 I. Subsidiary Information 130 ITEM 11.
QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK 130 ITEM 12.
DESCRIPTION OF SECURITIES OTHER THAN EQUITY SECURITIES
DESCRIPTION OF SECURITIES OTHER THAN EQUITY SECURITIES 131 A. Debt Securities 131 B. Warrants and Rights 131 C. Other Securities 131 D. American Depositary Shares 131 PART II 132 ITEM 13. DEFAULTS, DIVIDEND ARREARAGES AND DELINQUENCIES 132 ITEM 14. MATERIAL MODIFICATIONS TO THE RIGHTS OF SECURITY HOLDERS AND USE OF PROCEEDS 132 ITEM 15.
CONTROLS AND PROCEDURES
CONTROLS AND PROCEDURES 132 A. Disclosure Controls and Procedures 132 B. Management's Annual Report on Internal Control Over Financial Reporting 133 C. Attestation Report of the Registered Public Accounting Firm 134 D. Changes in Internal Controls over Financial Reporting 134 ii ITEM 16A. AUDIT COMMITTEE FINANCIAL EXPERT 134 ITEM 16B. CODE OF ETHICS 134 ITEM 16C. PRINCIPAL ACCOUNTANT FEES AND SERVICES 135 ITEM 16D. EXEMPTIONS FROM THE LISTING STANDARDS FOR AUDIT COMMITTEES 135 ITEM 16E. PURCHASES OF EQUITY SECURITIES BY THE ISSUER AND AFFILIATED PURCHASERS 135 ITEM 16F. CHANGES IN REGISTRANT'S CERTIFYING ACCOUNTANT 135 ITEM 16G. CORPORATE GOVERNANCE 135 ITEM 16H. MINE SAFETY DISCLOSURE 135 PART III 136 ITEM 17.
FINANCIAL STATEMENTS
FINANCIAL STATEMENTS 136 iii INTRODUCTORY NOTES Use of Certain Defined Terms Except as otherwise indicated by the context and for the purposes of this Annual Report only, references in this Annual Report to: "App-Chem Health" are to Shaanxi App-Chem Health Industry Co., Ltd., one of our wholly owned subsidiaries incorporated on April 17, 2006 in Tongchuan "App-Chem Ag-tech" are to Shaanxi App-Chem Ag-tech Co., Ltd., one of our wholly owned subsidiaries incorporated on April 19, 2013 in Dali County, Shaanxi Province in accordance with PRC laws; "App-Chem Guangzhou" are to App-Chem Bio (Tech) (Guangzhou) Co., Ltd., one of our wholly owned subsidiaries incorporated on April 27, 2018 in Guangzhou "Bon Natural Life," "the Company," "we," "us," "our company" or "our" are to Bon Natural Life Limited a Cayman Islands corporation, its subsidiaries and its consolidated affiliated entities; Bon Natural Life U.S.A." are to Bon Natural Life U.S.A. Limited, one of our wholly owned subsidiaries incorporated on February 7, 2023 in accordance with the laws and regulations in the State of Nevada; "Bozhou DT" are to Bozhou Dietary Therapy Health Technology Co., Ltd., one of our wholly owned subsidiaries incorporated on March 9, 2023 in accordance with PRC laws; "China" or the "PRC" are to the People's Republic of China, including Hong Kong and Macau, and excluding, for the purposes of this Annual Report only, Taiwan; "Class A Ordinary Shares" or "Shares" are to our Class A ordinary shares, par value $0.001 per share; "C lass B Ordinary Shares" are to our Class B ordinary shares, par value $0.001 per share; "Operating subsidiaries" or "PRC subsidiaries" are to Xi'an App-Chem Bio(Tech) Co., Ltd., a PRC company, and its subsidiary entities incorporated in the PRC; "Tea Essence" are to Tea Essence Limited, one of our wholly owned subsidiaries incorporated on January 9, 2020 in accordance with